RCUS logo

Arcus Biosciences (RCUS) Free Cash Flow

Annual FCF

-$176.00 M
+$154.00 M+46.67%

December 31, 2024

Summary

Performance

1-Year Change

+46.67%

3-Year Change

+37.59%

5-Year Change

-133.46%

15-Year Change

-475.67%

RCUS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.91%
RCUS annual free cash flow is higher than 7.91% of companies in Healthcare sector

High & Low

All-time High

$432.00 M
RCUS annual free cash flow is currently -140.74% below its historical high of $432.00 million

3-Year Low

-$330.00 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RCUS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RCUS next annual earnings announcement has not yet been scheduled

OtherRCUScash flowmetrics:

Annual CFO

-$170.00 M
RCUS annual cash flow from operations is -$170.00 million

Annual CFF

$277.00 M
RCUS annual cash flow from financing activities is $277.00 million

Annual CFI

-$84.00 M
RCUS annual cash flow from investing activities is -$84.00 million

Annual CAPEX

$6.00 M
RCUS annual capital expenditures is $6.00 million

Quarterly FCF

-$101.00 M
-$126.00 M-504.00%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-7.45%

3-Year Change

-43.55%

5-Year Change

-944.79%

RCUS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.65%
RCUS quarterly free cash flow is higher than 2.65% of companies in Healthcare sector

High & Low

All-time High

$651.00 M
RCUS quarterly free cash flow is currently -115.51% below its historical high of $651.00 million

3-Year Low

-$101.00 M
RCUS quarterly free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUScash flowmetrics:

Quarterly CFO

-$100.00 M
RCUS quarterly cash flow from operations is -$100.00 million

Quarterly CFF

-$2.00 M
RCUS quarterly cash flow from financing activities is -$2.00 million

Quarterly CFI

$51.00 M
RCUS quarterly cash flow from investing activities is $51.00 million

Quarterly CAPEX

$1.00 M
RCUS quarterly capital expenditures is $1.00 million

TTM FCF

-$176.00 M
-$7.00 M-4.14%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+46.67%

3-Year Change

+37.59%

5-Year Change

-133.46%

RCUS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.78%
RCUS TTM free cash flow is higher than 7.78% of companies in Healthcare sector

High & Low

All-time High

$447.02 M
RCUS TTM free cash flow is currently -139.37% below its historical high of $447.02 million

3-Year Low

-$330.00 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUScash flowmetrics:

TTM CFO

-$170.00 M
RCUS TTM cash flow from operations is -$170.00 million

TTM CFF

$277.00 M
RCUS TTM cash flow from financing activities is $277.00 million

TTM CFI

-$84.00 M
RCUS TTM cash flow from investing activities is -$84.00 million

TTM CAPEX

$6.00 M
RCUS TTM capital expenditures is $6.00 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$176.00 M
RCUS annual free cash flow is -$176.00 million

Annual CFO

-$170.00 M
RCUS annual cash flow from operations is -$170.00 million

Annual CAPEX

$6.00 M
RCUS annual capital expenditures is $6.00 million

RCUS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.7%-7.5%+46.7%
3 y3 years+37.6%-43.5%+37.6%
5 y5 years-133.5%-944.8%-133.5%

RCUS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-140.7%+46.7%-115.5%at low-139.4%+46.7%
5 y5-year-140.7%+46.7%-115.5%at low-139.4%+46.7%
alltimeall time-140.7%+46.7%-115.5%at low-139.4%+46.7%

Arcus Biosciences Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-$176.00 M(-46.7%)
-$101.00 M(-504.0%)
-$176.00 M(+4.1%)
Sep 2024
-
$25.00 M(-126.6%)
-$169.00 M(-36.7%)
Jun 2024
-
-$94.00 M(+1466.7%)
-$267.00 M(+13.6%)
Mar 2024
-
-$6.00 M(-93.6%)
-$235.00 M(-28.8%)
Dec 2023
-$330.00 M(-176.4%)
-$94.00 M(+28.8%)
-$330.00 M(+10.0%)
Sep 2023
-
-$73.00 M(+17.7%)
-$300.00 M(-3.2%)
Jun 2023
-
-$62.00 M(-38.6%)
-$310.00 M(-3.1%)
Mar 2023
-
-$101.00 M(+57.8%)
-$320.00 M(-174.1%)
Dec 2022
$432.00 M(-253.2%)
-$64.00 M(-22.9%)
$432.00 M(+1.5%)
Sep 2022
-
-$83.00 M(+15.3%)
$425.64 M(-4.8%)
Jun 2022
-
-$72.00 M(-111.1%)
$447.02 M(+1.8%)
Mar 2022
-
$651.00 M(-1025.2%)
$438.96 M(-255.7%)
Dec 2021
-$282.00 M(-361.1%)
-$70.36 M(+14.2%)
-$282.00 M(+7.2%)
Sep 2021
-
-$61.62 M(-23.0%)
-$263.15 M(-2027.2%)
Jun 2021
-
-$80.07 M(+14.5%)
$13.65 M(-80.4%)
Mar 2021
-
-$69.96 M(+35.8%)
$69.53 M(-35.6%)
DateAnnualQuarterlyTTM
Dec 2020
$108.00 M(-243.3%)
-$51.51 M(-123.9%)
$108.00 M(-27.9%)
Sep 2020
-
$215.19 M(-989.5%)
$149.85 M(-260.6%)
Jun 2020
-
-$24.19 M(-23.2%)
-$93.30 M(+4.4%)
Mar 2020
-
-$31.49 M(+225.7%)
-$89.41 M(+18.6%)
Dec 2019
-$75.39 M(+61.3%)
-$9.67 M(-65.4%)
-$75.39 M(+3.1%)
Sep 2019
-
-$27.95 M(+37.7%)
-$73.08 M(+25.9%)
Jun 2019
-
-$20.30 M(+16.2%)
-$58.03 M(+16.3%)
Mar 2019
-
-$17.47 M(+137.2%)
-$49.91 M(+6.8%)
Dec 2018
-$46.74 M(+52.9%)
-$7.37 M(-42.9%)
-$46.74 M(+94.1%)
Sep 2018
-
-$12.89 M(+5.8%)
-$24.08 M(-33.6%)
Jun 2018
-
-$12.18 M(-14.8%)
-$36.26 M(+9.4%)
Mar 2018
-
-$14.30 M(-193.5%)
-$33.14 M(+8.4%)
Dec 2017
-$30.57 M(+79.4%)
$15.29 M(-161.0%)
-$30.57 M(-33.3%)
Sep 2017
-
-$25.07 M(+176.8%)
-$45.87 M(+120.6%)
Jun 2017
-
-$9.06 M(-22.8%)
-$20.79 M(+77.2%)
Mar 2017
-
-$11.74 M
-$11.74 M
Dec 2016
-$17.04 M
-
-

FAQ

  • What is Arcus Biosciences annual free cash flow?
  • What is the all time high annual FCF for Arcus Biosciences?
  • What is Arcus Biosciences annual FCF year-on-year change?
  • What is Arcus Biosciences quarterly free cash flow?
  • What is the all time high quarterly FCF for Arcus Biosciences?
  • What is Arcus Biosciences quarterly FCF year-on-year change?
  • What is Arcus Biosciences TTM free cash flow?
  • What is the all time high TTM FCF for Arcus Biosciences?
  • What is Arcus Biosciences TTM FCF year-on-year change?

What is Arcus Biosciences annual free cash flow?

The current annual FCF of RCUS is -$176.00 M

What is the all time high annual FCF for Arcus Biosciences?

Arcus Biosciences all-time high annual free cash flow is $432.00 M

What is Arcus Biosciences annual FCF year-on-year change?

Over the past year, RCUS annual free cash flow has changed by +$154.00 M (+46.67%)

What is Arcus Biosciences quarterly free cash flow?

The current quarterly FCF of RCUS is -$101.00 M

What is the all time high quarterly FCF for Arcus Biosciences?

Arcus Biosciences all-time high quarterly free cash flow is $651.00 M

What is Arcus Biosciences quarterly FCF year-on-year change?

Over the past year, RCUS quarterly free cash flow has changed by -$7.00 M (-7.45%)

What is Arcus Biosciences TTM free cash flow?

The current TTM FCF of RCUS is -$176.00 M

What is the all time high TTM FCF for Arcus Biosciences?

Arcus Biosciences all-time high TTM free cash flow is $447.02 M

What is Arcus Biosciences TTM FCF year-on-year change?

Over the past year, RCUS TTM free cash flow has changed by +$154.00 M (+46.67%)